BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38393518)

  • 1. The possible effects of the MTOR polymorphisms on preeclampsia susceptibility, severity, and onset: a case-control study and in silico analysis.
    Rezaei M; Ghasemi M; Saravani M; Ghahghayi F; Shahraki-Ghadim H; Salimi S
    Mol Biol Rep; 2024 Feb; 51(1):335. PubMed ID: 38393518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphism in DGCR8 is associated with late onset of preeclampsia.
    Huang X; Li Z; Lei J; Wang D; Zhang Y
    BMC Med Genet; 2019 Sep; 20(1):151. PubMed ID: 31484500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of the mTOR gene polymorphisms rs2536 and rs2295080 on breast cancer risk in the Chinese population.
    Zhao Y; Diao Y; Wang X; Lin S; Wang M; Kang H; Yang P; Dai C; Liu X; Liu K; Li S; Zhu Y; Dai Z
    Oncotarget; 2016 Sep; 7(36):58174-58180. PubMed ID: 27533457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The early-onset preeclampsia is associated with MTHFR and FVL polymorphisms.
    Salimi S; Saravani M; Yaghmaei M; Fazlali Z; Mokhtari M; Naghavi A; Farajian-Mashhadi F
    Arch Gynecol Obstet; 2015 Jun; 291(6):1303-12. PubMed ID: 25480409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of mTOR and cancer risk: a systematic review and updated meta-analysis.
    Zining J; Lu X; Caiyun H; Yuan Y
    Oncotarget; 2016 Aug; 7(35):57464-57480. PubMed ID: 27462867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association of mammalian target of rapamycin gene polymorphisms with the risk of pediatric epilepsy].
    Yue X; Zhao PW; Liu ZS; Wu GF; Tu F; Hu JS; He XL
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):560-4. PubMed ID: 26108313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 12B rs3212227 and rs6887695 single nucleotide polymorphisms are associated with the susceptibility to preeclampsia: Genetic, haplotype and bioinformatics analysis.
    Jahantigh D; Ghazaey Zidanloo S; Moossavi SZ; Forghani F
    Cytokine; 2023 Apr; 164():156166. PubMed ID: 36842370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of the effect of rs2295080 and rs2536 polymorphisms within the mTOR gene on cancer risk.
    Qi GH; Wang CH; Zhang HG; Yu JG; Ding F; Song ZC; Xia QH
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32597485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-27 variants might be genetic risk factors for preeclampsia: based on genetic polymorphisms, haplotypes and in silico approach.
    Jahantigh D; Ghazaey Zidanloo S; Forghani F; Doroudian M
    Mol Biol Rep; 2020 Oct; 47(10):7929-7940. PubMed ID: 33011926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of Genetic Polymorphisms of mTOR rs2295080 T/G and rs1883965 G/A with Susceptibility of Urinary System Cancers.
    Min Z; Mi Y; Lv Z; Sun Y; Tang B; Wu H; Zhang Z; Pan H; Zhang Y; Lu C; Zuo L; Zhang L
    Dis Markers; 2022; 2022():1720851. PubMed ID: 35082928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of TNF-α and TLR4 polymorphisms in the placenta of pregnant women complicated by preeclampsia and in silico analysis.
    Mohammadpour-Gharehbagh A; Jahantigh D; Eskandari M; Eskandari F; Rezaei M; Zeynali-Moghaddam S; Teimoori B; Salimi S
    Int J Biol Macromol; 2019 Aug; 134():1205-1215. PubMed ID: 31071395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the mTOR and AKT genes polymorphisms on systemic lupus erythematosus risk.
    Saravani M; Shahraki-Ghadimi H; Maruei-Milan R; Mehrabani M; Mirzamohammadi S; Nematollahi MH
    Mol Biol Rep; 2020 May; 47(5):3551-3556. PubMed ID: 32319007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants in 3'-UTRs of MTHFR in the pregnancies complicated with preeclampsia and bioinformatics analysis.
    Mohammadpour-Gharehbagh A; Salimi S; Keshavarzi F; Saeidian F; Mousavi M; Teimoori B; Esmaeilipour M; Mokhtari M
    J Cell Biochem; 2018 Jan; 119(1):773-781. PubMed ID: 28657672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long non-coding RNA H19 rs217727 polymorphism is associated with PE susceptibility.
    Harati-Sadegh M; Kohan L; Teimoori B; Salimi S
    J Cell Biochem; 2018 Jul; 119(7):5473-5480. PubMed ID: 29380421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin system gene variants and risk of early- and late-onset preeclampsia: A single center case-control study.
    Procopciuc LM; Nemeti G; Buzdugan E; Iancu M; Stamatian F; Caracostea G
    Pregnancy Hypertens; 2019 Oct; 18():1-8. PubMed ID: 31442828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development.
    Maruei-Milan R; Saravani M; Heidari Z; Asadi-Tarani M; Salimi S
    IUBMB Life; 2020 Dec; 72(12):2601-2610. PubMed ID: 33107190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between angiotensin converting enzyme gene polymorphism (rs4343) and susceptibility to gestational hypertension and preeclampsia in pregnant women.
    Kamal RM; Morsy AA; Abd Elalim AA; Abd Elbaky NM; Abdel Halim HW
    Egypt J Immunol; 2023 Apr; 30(2):150-161. PubMed ID: 37031464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association study of M235T and A-6G polymorphisms in angiotensinogen gene with risk of developing preeclampsia in Iranian population.
    Alaee E; Mirahmadi M; Ghasemi M; Kashani E; Attar M; Shahbazi M
    Ann Hum Genet; 2019 Nov; 83(6):418-425. PubMed ID: 31090060
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Akin S; Pinarbasi E; Bildirici AE; Cekin N
    J Obstet Gynaecol; 2022 Nov; 42(8):3464-3470. PubMed ID: 36369889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The possible role of maternal and placental
    Farajian-Mashhadi F; Eskandari F; Rezaei M; Eskandari F; Najafi D; Teimoori B; Moradi-Sharbabak M; Salimi S
    Clin Exp Hypertens; 2020; 42(2):171-176. PubMed ID: 31006279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.